齐鲁华信(830832) - 2023 Q1 - 季度财报

Financial Performance - Operating revenue for Q1 2023 was CNY 108,553,565.66, down 34.20% from CNY 164,976,203.10 in Q1 2022[10] - Net profit attributable to shareholders for Q1 2023 was CNY 1,512,294.75, a decline of 87.05% compared to CNY 11,675,274.18 in the same period last year[10] - The net cash flow from operating activities was negative CNY 20,566,224.69, a decrease of 606.63% compared to CNY 4,059,428.74 in Q1 2022[10] - Total operating revenue for Q1 2023 was CNY 108,553,565.66, a decrease from CNY 164,976,203.10 in Q1 2022, representing a decline of approximately 34%[41] - Total operating costs for Q1 2023 were CNY 106,426,639.95, down from CNY 149,910,010.49 in Q1 2022, indicating a reduction of about 29%[41] - Net profit for Q1 2023 was CNY 1,512,294.75, significantly lower than CNY 11,675,274.18 in Q1 2022, reflecting a decrease of approximately 87%[42] - The company reported a net cash outflow from operating activities of CNY -20,566,224.69 in Q1 2023, compared to a net inflow of CNY 4,059,428.74 in Q1 2022[47] - The total comprehensive income for Q1 2023 was CNY 143,810.23, significantly lower than CNY 2,742,593.49 in Q1 2022[46] Assets and Liabilities - Total assets as of March 31, 2023, were CNY 1,057,217,872.45, a decrease of 0.31% compared to the end of 2022[10] - The company's asset-liability ratio (consolidated) was 27.58%, down from 27.98% at the end of 2022[10] - The company's current assets totaled CNY 634,297,031.70, down from CNY 639,223,426.75 in the previous period[33] - The company's total liabilities decreased from CNY 238,486,030.66 to CNY 218,692,069.38 in current liabilities[34] - Total liabilities as of March 31, 2023, were CNY 137,419,243.81, down from CNY 143,919,521.22 at the end of 2022, showing a reduction of about 4%[39] - The company's fixed assets decreased from CNY 242,594,971.72 to CNY 236,155,667.35[34] - The company's non-current assets totaled CNY 422,920,840.75, slightly up from CNY 421,329,129.92[34] Shareholder Information - The total number of ordinary shares outstanding is 138,763,865, with 89.98% being freely tradable shares[20] - The largest shareholder, Mingyue Xin, holds 12,560,110 shares, representing 9.05% of total shares[21] - The company has a total of 6,484 ordinary shareholders[20] - The core employees' shareholding decreased by 184,326 shares, resulting in a total of 7,066,553 shares, or 5.09%[20] - The total number of restricted shares is 13,910,261, accounting for 10.02% of total shares[20] - The second-largest shareholder, Shandong Xinghua, holds 5,803,200 shares, which is 4.18% of total shares[21] - The top ten shareholders collectively hold 38,387,866 shares, which is 27.66% of total shares[23] - The company does not have any preferred stock outstanding[24] - The largest shareholder's unrestricted shares amount to 9,420,083, while restricted shares total 3,140,027[23] - The total number of shares held by the third-largest shareholder, Ma Ning, is 3,581,511, representing 2.58%[22] Cash Flow and Expenses - Cash received from sales of goods and services was CNY 73,668,872.00, down 36.93% from CNY 116,799,685.26 in the same period last year[15] - Cash and cash equivalents decreased to CNY 24,224,242.67 as of March 31, 2023, from CNY 32,561,952.04 at the end of 2022, a decline of approximately 26%[37] - Cash and cash equivalents at the end of Q1 2023 were CNY 204,179,827.90, down from CNY 268,535,490.08 at the end of Q1 2022[48] - Cash inflow from financing activities was CNY 15,000,000.00, a decrease of 49.3% compared to CNY 29,600,000.00 in Q1 2022[50] - Cash paid for purchasing goods and services was CNY 17,334,305.65, an increase from CNY 16,486,399.16 in Q1 2022[50] - Cash paid to employees decreased to CNY 14,770,889.76 from CNY 16,270,636.79 in the same quarter last year[50] - Cash paid for taxes increased significantly to CNY 6,206,842.01 from CNY 2,587,624.18 in Q1 2022[50] Research and Development - Research and development expenses for Q1 2023 were CNY 4,047,607.87, compared to CNY 4,625,539.28 in Q1 2022, showing a decrease of approximately 12%[42] - Research and development expenses for Q1 2023 were CNY 2,071,221.62, a decrease of 12.2% from CNY 2,359,762.26 in Q1 2022[45]